Home
Scholarly Works
Impact of Guselkumab Versus Placebo and Adalimumab...
Conference

Impact of Guselkumab Versus Placebo and Adalimumab on Patient Reported Outcomes in Patients with and without Psoriatic Arthritis in a Phase 3 Pivotal Psoriasis Study

Authors

Puig L; Hang C; Vender R; Song M; You Y; Shen Y-K; Foley P

Volume

70

Publisher

WILEY

Publication Date

September 1, 2018

Name of conference

Annual Meeting of the American-College-of-Rheumatology (ACR) and Association-for-Rheumatology-Health-Professionals (ARHP)

Conference place

IL, Chicago

Conference start date

October 19, 2018

Conference end date

October 24, 2018

Conference proceedings

ARTHRITIS & RHEUMATOLOGY

ISSN

2326-5191

Contact the Experts team